BSXBOSTON SCIENTIFIC CORP

NYSE bostonscientific.com


$ 77.03 $ 0.01 (0.01 %)    

Friday, 28-Jun-2024 15:59:58 EDT
QQQ $ 479.98 $ -3.41 (-0.71 %)
DIA $ 391.11 $ -0.45 (-0.11 %)
SPY $ 544.70 $ -1.67 (-0.31 %)
TLT $ 91.77 $ -1.75 (-1.87 %)
GLD $ 215.03 $ 0.04 (0.02 %)
$ 77.01
$ 76.98
$ 77.03 x 200
$ 0.00 x 0
$ 76.71 - $ 77.42
$ 48.35 - $ 77.99
7,614,730
na
114.11B
$ 1.05
$ 64.65
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 07-30-2019 06-30-2019 10-Q
21 04-29-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 10-29-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-24-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

 needham-reiterates-buy-on-boston-scientific-maintains-82-price-target

Needham analyst Mike Matson reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $82 price target.

 boston-scientific-adds-stroke-prevention-to-vascular-portfolio-via-silk-road-medicals-13b-deal

Boston Scientific to acquire Silk Road Medical for $1.26 billion, enhancing its vascular portfolio with Silk Road's TCAR sy...

Core News & Articles

Boston Scientific expects to complete the transaction in the second half of 2024, subject to customary closing conditions. Sil...

Core News & Articles

The per share price represents an approximate 38% premium to the volume-weighted average share price of Silk Road Medical's...

 goldman-sachs-initiates-coverage-on-boston-scientific-with-buy-rating-announces-price-target-of-90

Goldman Sachs analyst David Roman initiates coverage on Boston Scientific (NYSE:BSX) with a Buy rating and announces Price T...

 argus-research-maintains-buy-on-boston-scientific-raises-price-target-to-95

Argus Research analyst John Eade maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $80 to $95.

 citigroup-maintains-buy-on-boston-scientific-raises-price-target-to-87

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $85 to $87.

 reported-saturday-modular-atp-study-of-boston-scientifics-mcrm-system-meets-safety-and-efficacy-endpoints

In addition to evaluating the safety and performance of the EMPOWER LP as a standalone pacemaker, the trial evaluated the abili...

 jim-cramer-recommends-buying-this-sports-betting-companys-stock-i-think-its-terrific

Sports betting app DraftKings is "terrific," Cramer says. The company recently reported Q1 revenue of $1.18 billion, up...

 boston-scientifics-upside-with-cardiology-devices-drives-momentum

Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoptio...